Group One Trading’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-16,839
Closed -$900K 5411
2016
Q1
$900K Sell
16,839
-6,863
-29% -$507K 0.01% 1254
2015
Q4
$2.68M Sell
23,702
-14,805
-38% -$1.63M 0.03% 677
2015
Q3
$4.53M Sell
38,507
-1,512
-4% -$197K 0.06% 380
2015
Q2
$3.1M Buy
40,019
+27,805
+228% +$1.82M 0.04% 514
2015
Q1
$707K Buy
12,214
+1,963
+19% +$83.3K 0.01% 1338
2014
Q4
$331K Buy
+10,251
New +$308K 0.01% 1869
2014
Q3
Sell
-19,887
Closed -$353K 5939
2014
Q2
$353K Buy
19,887
+6,613
+50% +$106K 0.01% 1935
2014
Q1
$266K Buy
+13,274
New +$257K ﹤0.01% 2197
2013
Q4
Sell
-4,047
Closed -$43K 6065
2013
Q3
$43K Buy
+4,047
New +$35.4K ﹤0.01% 3658

Other funds holding ANAC

Group One Trading's ANAC Position: Q2 2016 in Review

Group One Trading sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 16,839 shares — an estimated $900K sold.

Group One Trading first reported a position in ANAC in Q3 2013 and held it in 9 quarters. The position peaked at $4.53M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Group One Trading reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Group One Trading sold 16,839 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $900K.
  • Group One Trading first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2013 and held it in 9 quarters.
  • Group One Trading's ANACOR PHARMACEUTICALS INC COM position peaked at $4.53M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Group One Trading's 13F filing for Q2 2016, filed 12 Aug 2016.